Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells
María Eugenia Dávola(McMaster University), Karen Mossman(McMaster University)
Cited by 13
Related Papers
Novel Insights Into Immune Systems of Bats
|Frontiers in Immunology|2020|374
Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy
|Molecular Therapy|2013|116
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
|Communications Biology|2020|47
The Importance of Physiologically Relevant Cell Lines for Studying Virus–Host Interactions
|Viruses|2016|45
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
|Communications Biology|2021|23